ClearPoint Neuro, Inc.

NasdaqCM CLPT

ClearPoint Neuro, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -59.64%

ClearPoint Neuro, Inc. Net Income Margin is -59.64% for the Trailing 12 Months (TTM) ending September 30, 2024, a 38.25% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

ClearPoint Neuro, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -96.57%, a -15.86% change year over year.
ClearPoint Neuro, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -83.35%, a -10.73% change year over year.
ClearPoint Neuro, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -75.27%.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

NasdaqCM: CLPT

ClearPoint Neuro, Inc.

CEO	Mr. Joseph Michael Burnett
IPO Date	May 22, 2012
Location	United States
Headquarters	120 S. Sierra Avenue
Employees	107
Sector	Healthcare
Industries Medical Instruments 3D Printing Augmented Reality (AR) Autonomous Driving Biotechnology Clinical Trials Defense & Military Robotics

Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Key trends

Past 5 years